SHARE

KKR acquires majority stake in pharma royalty firm HCRx 

KKR is acquiring a majority stake in HealthCare Royalty Partners, which manages $3bn in pharma royalty assets. The deal reflects rising financing needs in biopharma, as drug companies increasingly turn to royalty deals amid a tough fundraising environment.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.